US-based biopharmaceutical company Nanotherapeutics has been acquired by Serum Institute of India.
Based in India, the acquirer company develops and manufactures drugs. Serum Institute has paid €45m ($48.85m) as an upfront payment for the €72m ($78.17m) acquisition, while the remaining consideration will be paid a year later.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
The acquisition is expected to help the Indian company to create a unit for polio vaccine injectables.
German healthcare company Fresenius has reached an agreement to acquire Akorn for $4.3bn.
The acquirer company will also assume the target company’s net debt of approximately $450m.
Akorn is a generic pharmaceutical company based in the US, whose acquisition is expected to complement Fresenius’ medicines division.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataNanoCarrier, a company based in Japan, is set to acquire US-based Tocagen.
Both companies involved in the acquisition are biotechnology firms.
